Nature and Classification
Dengue Virus is a mosquito-borne viral disease caused by the dengue virus, commonly abbreviated as DENV. It belongs to the genus Flavivirus and the family Flaviviridae.
The virus has four closely related serotypes:
- DENV-1
- DENV-2
- DENV-3
- DENV-4
Infection with one serotype generally produces long-term immunity against that same serotype. However, protection against the other serotypes is limited and temporary. A person can therefore suffer from dengue more than once during their lifetime.
A subsequent infection with a different serotype may carry a greater risk of severe disease in some individuals. This can occur because pre-existing antibodies may fail to neutralise the new serotype effectively and may instead facilitate viral entry into immune cells. This mechanism is known as antibody-dependent enhancement.
The dengue virus is an enveloped, single-stranded RNA virus. Its genetic material can undergo mutations, allowing different strains and serotypes to circulate across regions.
Transmission Cycle
Dengue is transmitted mainly through the bite of infected female Aedes mosquitoes, particularly:
Aedes aegypti is the principal vector. It commonly breeds in artificial collections of clean or relatively clean water found in containers such as water tanks, buckets, flowerpots, discarded tyres and coolers.
Unlike malaria-transmitting mosquitoes, Aedes mosquitoes usually bite during the daytime, with greater activity during the early morning and late afternoon.
The main transmission cycle is:
Infected human → mosquito bite → virus multiplies inside mosquito → mosquito bites another person → new human infection
A mosquito becomes infected after feeding on a person whose blood contains the dengue virus. After an incubation period inside the mosquito, the virus reaches its salivary glands. The mosquito can then transmit the virus during later bites.
Humans can transmit the virus to mosquitoes shortly before symptoms appear and for a limited period after the fever subsides. Direct person-to-person transmission does not normally occur. Rare transmission may occur through blood transfusion, organ transplantation and from mother to child around the time of birth.
Disease Development and Clinical Forms
After entering the human body, the virus infects immune cells and begins to multiply. The incubation period is usually several days, after which symptoms may appear.
A large proportion of dengue infections remain asymptomatic or produce only mild illness. Symptomatic cases commonly involve:
- sudden high fever;
- severe headache;
- pain behind the eyes;
- muscle and joint pain;
- nausea and vomiting;
- skin rash;
- mild bleeding from the nose or gums.
Dengue is sometimes called break-bone fever because of the intense muscle, bone and joint pain experienced by some patients.
The illness generally progresses through three phases:
Febrile phase: High fever, headache, body pain and rash are common.
Critical phase: This may begin when the fever starts declining. Increased permeability of blood vessels can cause plasma to leak into surrounding tissues. A falling fever therefore does not always indicate recovery.
Recovery phase: Leaked fluid is gradually reabsorbed, circulation stabilises and the patient’s condition improves.
Warning signs requiring urgent medical attention include:
- severe abdominal pain;
- persistent vomiting;
- bleeding from the gums or nose;
- blood in vomit or stool;
- rapid breathing;
- extreme weakness or restlessness;
- fluid accumulation;
- sudden fall in blood pressure.
Severe dengue may involve major plasma leakage leading to shock, severe bleeding or serious impairment of organs such as the liver, heart or brain.
Diagnosis and Treatment
Dengue cannot always be distinguished from chikungunya, malaria, Zika and other febrile illnesses only through symptoms. Laboratory testing may therefore be required.
During the first week of illness, diagnosis may involve:
- RT-PCR or other nucleic acid tests, which detect viral genetic material;
- NS1 antigen test, which detects a viral protein circulating in the blood.
After the early stage, IgM antibody testing becomes more useful because the immune system begins producing measurable antibodies against the virus.
A single positive IgG test is generally not sufficient to confirm a new acute infection because IgG antibodies may remain from an earlier dengue or related flavivirus infection.
There is no specific antiviral medicine that routinely eliminates the dengue virus. Treatment is mainly supportive and includes:
- adequate fluid intake;
- careful monitoring of blood pressure and urine output;
- paracetamol for fever and pain;
- intravenous fluids when clinically necessary;
- hospitalisation for warning signs or severe disease.
Aspirin and non-steroidal anti-inflammatory medicines such as ibuprofen are generally avoided because they may increase the risk of bleeding.
Early recognition of warning signs and appropriate fluid management substantially reduce mortality from severe dengue.
Prevention and Public-Health Concerns
Dengue prevention depends primarily on reducing contact between humans and infected mosquitoes and controlling mosquito breeding.
Important measures include:
- covering water-storage containers;
- emptying and cleaning coolers, pots and buckets regularly;
- removing discarded tyres and containers;
- using mosquito repellents;
- wearing clothing that covers the arms and legs;
- using window screens and mosquito nets;
- strengthening community surveillance and waste management.
Because Aedes mosquitoes often breed close to human habitation, household and neighbourhood-level action is essential. Fogging may temporarily reduce adult mosquitoes but does not eliminate breeding sites and therefore cannot replace source reduction.
Rapid urbanisation, unplanned settlements, inadequate water storage, population movement, rising temperatures and changing rainfall patterns have contributed to the geographical expansion of dengue.
Vaccines such as QDENGA can reduce disease burden in selected populations, but vaccination does not provide complete protection. Vector control, early diagnosis, public awareness and effective clinical care remain essential.
Conclusion
Dengue is not merely a seasonal fever but a complex viral disease shaped by mosquito ecology, urban conditions, population movement and interactions between different viral serotypes. Its control requires an integrated approach combining vector management, disease surveillance, vaccination, community participation and timely medical care.
